

Cover Story
																																	Conversation with The Cancer LetterFree
By Alexandria Carolan
William Kaelin and Gregg Semenza have a message for young scientists: do science for its own sake—and enjoy it.
In Brief
Drugs & Targets


Trending Stories
- Class action complaint alleging GRAIL insider fraud resubmitted after dismissal
 - Cancer centers adapt to life without site visits as NIH changes CCSG review
 - GRAIL to use new study results to seek FDA approval of Galleri MCD test
 - Jonathan Licht named president, chief scientific officer at Van Andel Institute
 - Friends publishes three white papers ahead of annual meeting
Topics: Clinical trials on rare cancers, combination drug trials, multi-regional studies - Duke brain cancer researcher Kyle Walsh named director of NIEHS
 
            













